Bioharvest Sciences (BHST) Current Deferred Revenue (2023 - 2025)

Bioharvest Sciences' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $492000.0 for Q4 2025.

• In Q4 2025, Current Deferred Revenue fell 45.7% year-over-year to $492000.0; the TTM figure through Dec 2025 stood at $492000.0 (down 45.7% YoY), while the FY2025 annual figure was $492000.0, down 45.7% from the prior year.
• Current Deferred Revenue was $492000.0 for Q4 2025 at Bioharvest Sciences, up from $438000.0 in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $1.1 million in Q1 2025 to a low of $438000.0 in Q3 2025.
• Historically, Current Deferred Revenue has averaged $797000.0 across 3 years, with a median of $906000.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue increased 26.18% in 2024, then plunged 45.7% in 2025.
• A 3-year view of Current Deferred Revenue shows it stood at $718000.0 in 2023, then climbed by 26.18% to $906000.0 in 2024, then slumped by 45.7% to $492000.0 in 2025.
• The last three Current Deferred Revenue figures came in at $492000.0 (Q4 2025), $438000.0 (Q3 2025), and $990000.0 (Q2 2025), per Business Quant data.